Blar i NTNU Open på forfatter "Coward, Eivind"

Viser treff 1-8 av 8

    • Assessment of the genetic and clinical determinants of hip fracture risk: Genome-wide association and Mendelian randomization study 

      Nethander, Maria; Coward, Eivind; Reimann, Ene; Grahnemo, Louise; Gabrielsen, Maiken Elvestad; Wibom, Carl; Nelis, Mari; Milani, Lili; Esko, Tõnu; Metspalu, Andres; Mägi, Reedik; Funck-Brentano, Thomas; Hoff, Mari; Langhammer, Arnulf; Pettersson-Kymmer, Ulrika; Hveem, Kristian; Ohlsson, Claes (Peer reviewed; Journal article, 2022)
      Hip fracture is the clinically most important fracture, but the genetic architecture of hip fracture is unclear. Here, we perform a large-scale hip fracture genome-wide association study meta-analysis and Mendelian ...

    • BRAF V600E mutation in early-stage multiple myeloma: good response to broad acting drugs and no relation to prognosis 

      Rustad, Even Holth; Dai, Hong Yan; Hov, Håkon; Coward, Eivind; Beisvag, Vidar; Myklebost, Ola; Hovig, Eivind; Nakken, Sigve; Vodak, Daniel; Meza-Zepeda, Leonardo A.; Sandvik, Arne Kristian; Wader, Karin Fahl; Misund, Kristine; Sundan, Anders; Aarset, Harald; Waage, Anders (Journal article; Peer reviewed, 2015)
      In this study, we analyzed the prevalence and clone size of BRAF V600E mutation in 209 patients with multiple myeloma and related the results to clinical phenotype, response and survival. Biopsies were screened for BRAF ...

    • Clonal evolution after treatment pressure in multiple myeloma: heterogenous genomic aberrations and transcriptomic convergence 

      Misund, Kristine; Hofste op Bruinink, Davine; Coward, Eivind; Hoogenboezem, Remco M.; Rustad, Even Holth; Sanders, Mathijs A.; Rye, Morten Beck; Sponaas, Anne-Marit; van der Holt, Bronno; Zweegman, Sonja; Hovig, Eivind; Meza, Leonardo Zepeda; Sundan, Anders; Myklebost, Ola; Sonneveld, Pieter; Waage, Anders (Peer reviewed; Journal article, 2022)
      We investigated genomic and transcriptomic changes in paired tumor samples of 29 in-house multiple myeloma (MM) patients and 28 patients from the MMRF CoMMpass study before and after treatment. A change in clonal composition ...

    • The HUNT study: A population-based cohort for genetic research 

      Brumpton, Ben Michael; Graham, Sarah; Surakka, Ida; Skogholt, Anne Heidi; Løset, Mari; Fritsche, Lars G.; Wolford, Brooke; Zhou, Wei; Nielsen, Jonas Bille; Holmen, Oddgeir Lingaas; Gabrielsen, Maiken Elvestad; Thomas, Laurent; Bhatta, Laxmi; Rasheed, Humaira; Zhang, He; Kang, Hyun Min; Hornsby, Whitney; Moksnes, Marta Riise; Coward, Eivind; Melbye, Mads; Giskeødegård, Guro F.; Fenstad, Jørn; Krokstad, Steinar; Næss, Marit; Langhammer, Arnulf; Boehnke, Michael; Abecasis, Gonçalo R.; Åsvold, Bjørn Olav; Hveem, Kristian; Willer, Cristen J. (Peer reviewed; Journal article, 2022)
      The Trøndelag Health Study (HUNT) is a population-based cohort of ∼229,000 individuals recruited in four waves beginning in 1984 in Trøndelag County, Norway. Approximately 88,000 of these individuals have available genetic ...

    • Identification of three bacterial species associated with increased appendicular lean mass: the HUNT study 

      Grahnemo, Louise; Nethander, Maria; Coward, Eivind; Gabrielsen, Maiken Elvestad; Sree, Satya; Billod, Jean-Marc; Sjögren, Klara; Engstrand, Lars; Dekkers, Koen F.; Fall, Tove; Langhammer, Arnulf; Hveem, Kristian; Ohlsson, Claes (Peer reviewed; Journal article, 2023)
      Appendicular lean mass (ALM) associates with mobility and bone mineral density (BMD). While associations between gut microbiota composition and ALM have been reported, previous studies rely on relatively small sample sizes. ...

    • Monitoring multiple myeloma by quantification of recurrent mutations in serum 

      Rustad, Even Holth; Coward, Eivind; Skytøen, Emilie R; Misund, Kristine; Holien, Toril; Standal, Therese; Børset, Magne; Beisvag, Vidar; Myklebost, Ola; Meza, Leonardo Zepeda; Hong, Yan Dai; Sundan, Anders; Waage, Anders (Journal article; Peer reviewed, 2017)
      Circulating tumor DNA is a promising biomarker to monitor tumor load and genome alterations. We explored the presence of circulating tumor DNA in multiple myeloma patients and its relation to disease activity during long-term ...

    • Mutational analysis and protein profiling predict drug sensitivity in multiple myeloma cell lines 

      Giliberto, Mariaserena; Miranda Santana, Leonardo; Holien, Toril; Misund, Kristine; Nakken, Sigve; Vodak, Daniel; Hovig, Eivind; Meza, Leonardo Zepeda; Coward, Eivind; Waage, Anders; Tasken, Kjetil; Skånland, Sigrid S (Peer reviewed; Journal article, 2022)
      Introduction: Multiple myeloma (MM) is a heterogeneous disease where cancer-driver mutations and aberrant signaling may lead to disease progression and drug resistance. Drug responses vary greatly, and there is an unmet ...

    • Transplantation of gut microbiota from old mice into young healthy mice reduces lean mass but not bone mass 

      Lawenius, Lina; Cowardin, Carrie; Grahnemo, Louise; Scheffler, Julia M.; Horkeby, Karin; Engdahl, Cecilia; Wu, Jianyao; Vandenput, Liesbeth; Koskela, Antti; Tukkanen, Juha; Coward, Eivind; Hveem, Kristian; Langhammer, Arnulf; Abrahamsson, Sanna; Gordon, Jeffrey I.; Sjögren, Klara; Ohlsson, Claes (Peer reviewed; Journal article, 2023)
      Aging is associated with low bone and lean mass as well as alterations in the gut microbiota (GM). In this study, we determined whether the reduced bone mass and relative lean mass observed in old mice could be transferred ...